Morgan Stanley tracks prescription trends for US neurology drugs
Go back to Morgan Stanley tracks prescription trends for US neurology drugs| ACADIA HEALTHCARE (NASDAQ: ACHC) | Delayed: 28.51 -0.86 (2.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.37 | 52 Week High | $70.84 | |||
| Open | $29.41 | 52 Week Low | $34.40 | |||
| Day High | $29.78 | P/E | 33.15 | |||
| Day Low | $28.09 | EPS | $0.86 | |||
| Volume | 2,231,382 | |||||
| (NASDAQ: AXSM) | Delayed: 193.45 -9.65 (4.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $203.10 | 52 Week High | $15.74 | |||
| Open | $204.01 | 52 Week Low | $5.37 | |||
| Day High | $204.70 | P/E | N/A | |||
| Day Low | $189.05 | EPS | $0.00 | |||
| Volume | 912,948 | |||||
| (NYSE: IQV) | Delayed: 267.86 -2.23 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $270.09 | 52 Week High | $ | |||
| Open | $270.66 | 52 Week Low | $ | |||
| Day High | $277.40 | P/E | N/A | |||
| Day Low | $267.42 | EPS | $ | |||
| Volume | 1,111,781 | |||||
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 139.49 -2.76 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.25 | 52 Week High | $58.46 | |||
| Open | $141.97 | 52 Week Low | $31.25 | |||
| Day High | $142.25 | P/E | N/A | |||
| Day Low | $139.32 | EPS | $-0.69 | |||
| Volume | 1,739,114 | |||||
